This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. If you’re pregnant or hoping to become pregnant, it’s ...

Semaglutide is not the only medication in this drug class. Eli Lilly has developed its own GLP-1 receptor agonist, ...

Explore the benefits and side effects of popular weight loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound. Learn how ...

GLP-1 drugs like Ozempic are a popular choice when it comes to losing weight, but they can have a steep cost, which West Virginian's seem willing to pay.

Sun Pharma receives DCGI approval to launch generic Wegovy semaglutide in India after patent expiry in March 2026. Check ...

India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...

Besides Sun Pharma, a growing roster of Indian drugmakers is lining up cheaper generic versions of semaglutide ahead of the ...

DCGI approval to Sun Pharma comes amid an ongoing patent dispute with Novo Nordisk in the Delhi High Court. The case relates ...

Swiss pharma giant Roche Holding AG's RHHBY 2025 results were affected by currency headwinds. Sales totaled $74.4 billion, ...

Smith ⁠Drug asked the court for an unspecified amount of monetary damages on behalf of a proposed class of Victoza purchasers ...

A nationwide aspirin shortage has left pharmacies struggling to meet demand, raising concerns for heart patients who rely on ...

With just a few months to go before Eli Lilly expects to launch its own oral GLP-1 obesity drug, Novo Nordisk is making the ...